Procope Medicals Company Research Report

Company Overview

Name and Mission of the Company

• Name: Procope Medicals

• Mission: The mission of Procope Medicals is to offer the best possible quality of life to patients suffering from terminal heart failure while minimizing the risks of complications as much as possible.

Founding Details

• Founded by:

• Saïd Chabane: CEO and Chief Scientific Officer, with over 30 years of experience in fluid engineering and business management.

• Samuel Plumejault: Co-founder and Technical Director.

• Stéphanie Gouraud: Co-founder and Operations and Communications Manager.

Headquarters

• Location: 16 Boulevard Joliot Curie, 44200 Nantes, France

Key People

• Saïd Chabane: CEO - Director of Scientific Research

• Samuel Plumejault: Co-founder - Director of Technology

• Stéphanie Gouraud: Co-founder - Operations and Communications Manager

• Pierre Fleurance, Alba Thio i pera, Jeanne Bonnin, Céline Garnier, Marie Dallibert are significant contributors in various engineering, R&D, operations, and communication roles.

Number of Employees

• No information is available

Revenue

• No information is available

Recognition

• Known for: Developing innovative solutions for heart failure, particularly their artificial heart.

Products

Product Offerings

• Artificial Heart:

• Description: Designed to address the unmet need of terminal heart failure management and the scarcity of heart transplants with a focus on all-encompassing prosthetic adaptation.

• Key Features:

• An innovative artificial heart equipped with Remote Patient Monitoring (RPM) to assure patient safety and improve life quality.

• Integration of digital solutions for continuous remote monitoring of vital signs.

• Hemodynamic and hemocompatible design to minimize blood flow turbulence and clot formation.

• Two volumes (50CC and 70CC) for better adaptability to varying patient morphologies.

• In-vivo preclinical trials to start in 2024.

Recent Developments

Recent Developments in the Company

• Procope Medicals has recently moved to new offices fit for their growing needs, ideal for expanding their testing laboratory to accelerate artificial heart development.

• The Scientific Committee of Procope Medicals is at the forefront of innovating clinically and regulatory compliant artificial heart total solutions.

New Products Launched

• No information is available

New Features Added to Existing Products

• Remote Patient Monitoring (RPM): Capable of predicting, preventing, and managing medical events remotely, integrated into their artificial heart.

New Partnerships

• Collaborative research efforts with laboratories like BMBI at UTC, ONIRIS, and EFS in Nantes to expedite the study and testing phases for their total artificial heart.

Additional Notes

• Procope Medicals is actively working on ensuring their artificial heart is universally compatible for most patients and entirely implantable for optimal quality of life.

• Their ongoing preclinical phase focuses on human biocompatibility and performance of artificial heart membranes.

• The company's digital solutions aim to significantly reduce healthcare costs, hospitalizations, and improve healthcare response times.

Sources

• Contact information: [sgouraud@procope-medicals.com](mailto:sgouraud@procope-medicals.com)

• Phone: 02 53 35 15 34

• For more updates, visit their [LinkedIn page](https://preprod.procopemedicals.com).